OpenVSafe by OpenVAERS
Search V-safe

29K-34702-30253

2 vaccinations 3 coded responses 8 check-ins 3 free-text entries 2 call cases
Sex
Male
Age at first dose
66+
ZIP prefix
934 / CA
Registered
2021-03-07
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Died per free text

Timeline

  1. 2021-01-21
    Dose 1 — Moderna
  2. 2021-02-18
    Dose 2 — Moderna
  3. 2021-03-07
    Registered in v-safe
  4. 2021-03-07
    Survey response — day 14, dose 2
    MedDRA: Injection site pain, Lethargy — Feeling: Good
    Free text: LethargyInjection site soreness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-11
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  6. 2021-03-18
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  7. 2021-03-25
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  8. 2021-04-04
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  9. 2021-05-20
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-08-19
    Survey response — 6 months, dose 2
    MedDRA: Hospitalisation, Mechanical ventilation, Myasthenia gravis, Neurotoxicity — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Symptoms: June 23 admitted for sudden onset myasthenia gravis thought to be related to receiving Opdivo immunotherapy - admitted to St Johns Providence Santa Monica CA and transferred and now at Barlow Respiratory Hospital Los Angeles, CA on ventilator · Healthcare visit (other): Neurotoxic reaction - on Ventilatorn
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  11. 2021-08-19
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  12. 2021-08-27
  13. 2022-02-20
    Survey response — 12 months, dose 2
    MedDRA: Death, Hospitalisation, Myasthenia gravis, Myocarditis, SARS-CoV-2 test negative, Unevaluable event — Feeling: Poor · Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Symptoms: After Moderna received 2 half doses of Opdivo in June 2021 - developed severe myocarditis and Myasthenia Gravis. The end result after 230 days in acute hospital setting was death in Feb 2022. Tested Covid negative · Healthcare visit (other): June 23, 2020 to Feb 8, 2022
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-02-20
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Hospitalization · 1 call case(s)
  15. 2022-02-22

Vaccinations

DoseDateManufacturerCo-administered
12021-01-21Moderna
22021-02-18Moderna

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 5 — day 14, dose 2

2021-03-07

Symptoms: LethargyInjection site soreness

Release 9 — 6 months, dose 2

2021-08-19

Symptoms: June 23 admitted for sudden onset myasthenia gravis thought to be related to receiving Opdivo immunotherapy - admitted to St Johns Providence Santa Monica CA and transferred and now at Barlow Respiratory Hospital Los Angeles, CA on ventilator
Healthcare visit (other): Neurotoxic reaction - on Ventilatorn

Release 11 — 12 months, dose 2

Reports this person's death

2022-02-20

Symptoms: After Moderna received 2 half doses of Opdivo in June 2021 - developed severe myocarditis and Myasthenia Gravis. The end result after 230 days in acute hospital setting was death in Feb 2022. Tested Covid negative
Healthcare visit (other): June 23, 2020 to Feb 8, 2022

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVONeurotoxicity ✓ · ✓
HCVOUnevaluable event · · ✓
SDDeath · · ✓
SDHospitalisation ✓ · ✓
SDInjection site pain ✓ ✓ ✓
SDLethargy ✓ ✓ ✓
SDMechanical ventilation ✓ · ✓
SDMyasthenia gravis ✓ · ✓
SDMyocarditis · · ✓
SDSARS-CoV-2 test negative · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release